Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation | Synapse
April 15, 2026Open Access
Malpractice claims for pancreatic cancer in Norway: claim-rates, injury domains, claim outcomes and indemnity compensation
Key Points
Examine malpractice claims related to pancreatic cancer, focusing on claim rates and outcomes.
Analyzed claim data over a specified period
Identified causes of claims
Assessed approval rates and compensation amounts
Claim rate remained stable at 1.5%
One in five claims were approved
Diagnostic delay was the primary reason for claims
Abstract
The claim rate of 1.5% was stable, with about one in five claims approved. Diagnostic delay was the predominant cause, with several stakeholders involved across the healthcare system.